Search results
Author(s):
Ankeet Bhatt
Added:
12 months ago
ESC HF 25 - Secondary analysis of the FINEARTS-HF study shows finerenone treatment favourably influenced the risk of early heart failure readmission.Dr Ankeet Bhatt (Kaiser Permanante San Francisco Medical Center, San Francisco, US) discusses findings from the prespecified secondary analysis of the FINEARTS-HF trial (NCT04435626; Bayer). The placebo-controlled primary analysis investigated the…
View more
Left Atrium Role in Secondary Mitral Regurgitation
Author(s):
Markos Koukos
,
Yannis Dimitroglou
,
Dimitrios Tsartsalis
,
et al
Added:
2 years ago
Review Article
Author(s):
Harriette Van Spall
,
Luke Laffin
Added:
1 year ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial…
View more
Author(s):
María Iglesias Alonso
,
Jose Manuel Iglesias Sanmartin
Added:
1 month ago
Resistant Hypertension: An Overview
Author(s):
Giacomo Buso
,
Claudia Agabiti-Rosei
,
Matteo Lemoli
,
et al
Added:
1 year ago
Review Article
Author(s):
Jessica Ares-Blanco
,
Miguel García-Villarino
,
Carmen Lambert
,
et al
Added:
1 month ago
Author(s):
Raúl Ptaszynski Lanza
,
Fernando López Iglesias
,
Raúl Ludeña
,
et al
Added:
1 month ago
Author(s):
Thomas Weber
,
Erika SW Jones
,
Bryan Williams
Added:
1 year ago
The long term clinical implications of uncontrolled hypertension are well documented, but almost half of those with hypertension remain inadequately treated. In this symposium, our panel of three leading hypertension experts, Prof Thomas Weber (Klinikum Wels-Grieskirchen, Wels, AT), Prof Bryan Williams (University College London, London, UK) and Prof Erika Jones (University of Cape Town, Cape…
View more
Author(s):
Deepak L Bhatt
Added:
1 month ago
American College of Cardiology Congress 2026 – Dr Deepak Bhatt (Mount Sinai Fuster Heart Hospital, New York, US) joins us to discuss primary results from the MOMENTUM study (NCT06829537; Corcept Therapeutics) investigating the prevalence and clinical impact of endogenous hypercortisolism in patients with resistant hypertension.This prospective, cross-sectional observational study enrolled 1,143…
View more